Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Current Topics in Behavioral Neurosciences|February 11, 2011
Metabotropic glutamate receptors: their therapeutic potential in anxietyWill Spooren, Anne Lesage, Hilde Lavreysen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2002
Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonismNathalie Breysse, Christelle Baunez, Will Spooren, et al.
European Child & Adolescent Psychiatry|December 5, 2014
European clinical network: autism spectrum disorder assessments and patient characterisationKaren L Ashwood, Jan Buitelaar, Declan Murphy, et al.
Psychopharmacology|March 2, 2005
The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparisonTheresa M Ballard, Marie L Woolley, Eric Prinssen, et al.
Neuropharmacology|June 23, 2009
Pharmacological characterization of senktide-induced tail whipsRebecca E Nordquist, Theresa M Ballard, Brigitte Algeyer, et al.
Psychopharmacology|February 27, 2004
Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibitionWill Spooren, Cedric Mombereau, Martine Maco, et al.
Translational Psychiatry|April 16, 2020
Transcriptome signatures from discordant sibling pairs reveal changes in peripheral blood immune cell composition in Autism Spectrum DisorderMichele Filosi, Tony Kam-Thong, Laurent Essioux, et al.
Molecular Pharmacology|March 1, 2008
Me-talnetant and osanetant interact within overlapping but not identical binding pockets in the human tachykinin neurokinin 3 receptor transmembrane domainsPari Malherbe, Caterina Bissantz, Anne Marcuz, et al.
Neuron|April 17, 2012
Chronic pharmacological mGlu5 inhibition corrects fragile X in adult miceAubin Michalon, Michael Sidorov, Theresa M Ballard, et al.
Neuropharmacology|August 10, 2014
Mapping the binding pocket of a novel, high-affinity, slow dissociating tachykinin NK3 receptor antagonist: biochemical and electrophysiological characterizationPari Malherbe, Frédéric Knoflach, Anne Marcuz, et al.
Pageof 6